The Lancet Respiratory Medicine delivers comprehensive, clinically-focused coverage on all areas of respiratory medicine and critical care, including but not limited to: COPD, asthma, cystic fibrosis, IPF, pneumonia, influenza, tuberculosis, sarcoidosis, pulmonary hypertension, sleep medicine, respiratory infections, pulmonary vascular disease, lung cancer, tobacco control, thoracic and reconstructive surgery, mesothelioma, and palliative medicine. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Respiratory Medicine contains Original Research, Reviews, Personal Views, Comments, and News.

The Lancet Respiratory Medicine is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks of submission (on average) and published Online First on www.thelancet.com before appearing in print.

Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original Research, Reviews, Personal Views, and Comments. Visit http://ees.elsevier.com/thelancetrm to learn more about our editorial scope and aims and to submit your manuscript.

Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at www.thelancet.com.

To find out more about The Lancet Respiratory Medicine, visit www.thelancet.com/respiratory.

《柳叶刀呼吸医学》全面、以临床为重点，涵盖呼吸医学和重症监护的所有领域，包括但不限于：慢性阻塞性肺病、哮喘、囊性纤维化、特发性肺纤维化、肺炎、流感、结核病、结节病、肺动脉高压、睡眠医学、呼吸道感染、肺血管疾病、肺癌、烟草控制、胸外科和重建外科、间皮瘤和姑息医学。《柳叶刀呼吸医学》延续了《柳叶刀》发表影响医学实践的高影响力内容的传统，每月一期，都包含原创研究、评论、个人观点、评论和新闻。

《柳叶刀呼吸医学》经过严格编辑和同行评审，以确保其多样化内容的科学价值和临床相关性。原创研究在提交后 8 周内（平均）即可快速发表，并在 www.thelancet.com 上在线发表，然后才印刷出来。

该期刊现已被 PubMed、Journal Citation Reports® 和 Scopus 收录，接受原创研究、评论、个人观点和意见的投稿。请访问 http://ees.elsevier.com/thelancetrm 详细了解我们的编辑范围和目标，并提交您的稿件。

黄金或绿色开放获取适用于 Elsevier 与之有协议的选定资助机构资助的研究。该期刊还可通过 HINARI 计划或通过 www.thelancet.com 上的 IP 访问免费提供给中低收入国家的读者。

要了解有关《柳叶刀呼吸医学》的更多信息，请访问 www.thelancet.com/respiratory。

该刊已被国际权威数据库SCIE收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映RESPIRATORY SYSTEM-RESPIRATORY SYSTEM领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为38.7，平均审稿速度为 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。